C07D 497/00
Heterocyclic compounds containing in the condensed system at least one hetero ring
Official title: Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
C07D497/00 (Heterocyclic compounds containing in the condensed system at least one hetero ring) appears on 301 US grants and 294 published applications in this corpus.
Search patents in C07D- Granted patents
- 301
- Published applications
- 294
- Assignees
- 219
- Inventors
- 1,164
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 2 | 0 |
| 1978 | 1 | 0 |
| 1979 | 3 | 0 |
| 1980 | 4 | 0 |
| 1981 | 3 | 0 |
| 1982 | 6 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 2 | 0 |
| 1987 | 4 | 0 |
| 1988 | 2 | 0 |
| 1989 | 6 | 0 |
| 1990 | 4 | 0 |
| 1991 | 7 | 0 |
| 1992 | 5 | 0 |
| 1993 | 4 | 0 |
| 1994 | 4 | 0 |
| 1995 | 7 | 0 |
| 1996 | 18 | 0 |
| 1997 | 9 | 0 |
| 1998 | 9 | 0 |
| 1999 | 3 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 0 |
| 2002 | 3 | 4 |
| 2003 | 3 | 3 |
| 2004 | 2 | 6 |
| 2005 | 1 | 5 |
| 2006 | 1 | 11 |
| 2007 | 5 | 10 |
| 2008 | 2 | 6 |
| 2009 | 6 | 15 |
| 2010 | 11 | 13 |
| 2011 | 13 | 19 |
| 2012 | 8 | 10 |
| 2013 | 13 | 13 |
| 2014 | 8 | 14 |
| 2015 | 11 | 11 |
| 2016 | 8 | 10 |
| 2017 | 15 | 11 |
| 2018 | 5 | 10 |
| 2019 | 13 | 16 |
| 2020 | 8 | 10 |
| 2021 | 11 | 8 |
| 2022 | 14 | 10 |
| 2023 | 4 | 30 |
| 2024 | 13 | 18 |
| 2025 | 6 | 16 |
| 2026 | 9 | 15 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Anthelmintic compounds comprising a thienopyridine structure11 Aug 2026US 12,703,706 B2Intervet Inc.
- Benzolactam compounds as protein kinase inhibitors16 Jun 2026US 12,655,137 B2Otsuka Pharmaceutical Co., Ltd.
- Photochromic cyclic compound and curable composition containing the photochromic cyclic compound12 May 2026US 12,624,048 B2Tokuyama Corporation
- Compound, photoelectric device, light absorption sensor, sensor-embedded display panel, and electronic device28 Apr 2026US 12,612,378 B2Samsung Display Co., Ltd.
- Heteroaryl compounds as inhibitors of programmed necrosis pathway, composition and method using the same28 Apr 2026US 12,612,413 B2Accro Bioscience (HK) Limited
- Compound for organic photoelectric element, organic photoelectric element, image sensor and electronic device comprising the same8 Oct 2026US 2026/0314261 A1Duk San Neolux Co., Ltd.
- Photochromic compound, propargyl alcohol compound, curable composition, optical article, lens, and spectacles24 Sep 2026US 2026/0286216 A1Tokuyama Corporation
- Aryl tricyclic sting agonists and use thereof20 Aug 2026US 2026/0242392 A1Shenzhen Genuine Biotechnology Co., Ltd.
- Therapeutic alkaloid compounds13 Aug 2026US 2026/0234131 A1Sensorium Therapeutics, Inc.
- Polycyclic dianhydride and acid anhydride compounds having sulfonyl group, and polyimide-based resin and film using the same13 Aug 2026US 2026/0234332 A1Korea Advanced Institute of Science and Technology
Most cited
By later US patents
- 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles118US 4,804,663 AJanssen Pharmaceutica NV · 1989
- Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity82US 5,852,029 AIsrael Institute for Biological Research · 1998
- Substituted diimidazo [1,5-a: 4',5'-d]pyridines having antihypertensive activity77US 4,816,463 AWarner-Lambert Company · 1989
- Substituted 1H-indazole-3-carboxamides62US 5,037,844 ADuphar International Research B.V. · 1991
- Spiro compounds containing five-membered rings62US 5,534,520 A1996